Delivery Order SPE2DB20D2014-SPE2DB24FB20W
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,985.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200-unit vials of the pharmaceutical product Botox. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a $10,478.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 200-unit vials of Botox. This delivery order falls under Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,971.12 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. This order is for the provision of 200 unit vials of BOTOX and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,642.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BOTOX 200 unit vials. The $3,492.78 order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor to DLA, providing a range of pharmaceutical products and medical supplies in support of military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of Botox. The contract has a potential value of $13,971.12 and a period of performance through February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was awarded without any set-aside designations. This delivery order is part of Amerisourcebergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a $29,106.50 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 200 unit vials of BOTOX. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 200 unit vials of Botox. The firm-fixed-price contract is valued at $3,492.78 and has a period of performance through July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $58,213 contract is for the delivery of 200-unit vials of BOTOX medication to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999 through...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB20WDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 200-unit vials of Botox with a potential value of $1,164.26. This delivery order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA Troop Support Medical that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/4/24 |